1. Retroviruses and Onc Genes in Human Leukemias and Lymphomas --;1.1 Introduction --;1.2 Onc Genes in Leukemogenesis --;1.3 Retroviruses in Human Leukemia-Lymphoma --;2. Study of Differentiation and Proliferation of Leukemic Cells Using Myeloid Leukemia Cell Lines --;2.1 Introduction: Establishment of Human Myeloid Leukemia Cell Lines --;2.2 Human Erythroleukemia Cell Lines --;2.3 Study of Granulocyte Differentiation Using Myeloid Leukemic Cell Lines --;2.4 Induction of Macrophage-Like Differentiation of Human Acute Myelogenous Cells --;2.5 Genetic Analysis of Myeloid Differentiation --;2.6 Hormonal Modulation of Leukemic Cell Growth --;2.7 An In Vitro Model for Chemotherapy of Acute Myelogenous Leukemia --;2.8 Conclusion --;Acknowledgements --;References --;3. Biological Markers in Lymphoproliferative Disorders --;3.1 Introduction --;3.2 Immunological Markers --;3.3 Chronic B-Cell Malignancies --;3.4 Chronic T-Cell Malignancies --;3.5 Cytochemistry of Acid Hydrolases --;3.6 Chromosomes --;3.7 Conclusions --;Acknowledgements --;References --;4. Surface Marker Analysis of Acute Myeloblasts Leukemia --;4.1 Introduction --;4.2 Differentiation of Normal Myeloid Cells --;4.3 Detection of Myeloid-Lineage Antigens by Heteroantisera --;4.4 Production of Monoclonal Antibodies to Myeloid Cell Surface Antigens --;4.5 Monoclonal Antibodies Reactive with Human AML Cells --;4.6 Expression of Myeloid Differentiation Antigens on AML Cells --;4.7 Future Directions --;References --;5. Classification of 358 Cases of Acute Myeloid Leukemia by FAB Criteria: Analysis of Clinical and Morphologic Features --;5.1 Introduction --;5.2 Clinical and Morphologic Characteristics of the FAB Classes --;5.3 Comparison of FAB Classes of AML --;5.4 Discussion --;References --;6. Chemosensitivity of In Vitro Colony Forming Units as a Predictor of Response to Antileukemic Drugs --;6.1 Introduction --;6.2 Colony Assays --;6.3 Quantitation of Sensitivity to Antileukemic Drugs --;6.4 Correlations Between In Vitro Chemosensitivities of L-CFU and Clinical Response of the Patient --;6.5 Summary --;References --;7. Post-Remission Therapy for Acute Myelogenous Leukemia --;7.1 Introduction --;7.2 Role of Induction Therapy on Remission Duration --;7.3 Role of Consolidation Therapy on Remission Duration --;7.4 Role of Maintenance Chemotherapy in Prolonging Remissions --;7.5 The Role of Immunotherapy in Maintenance --;7.6 Prognostic Variables Predicting for Prolonged Remission Duration --;7.7 Central Nervous System Leukemia --;7.8 Bone Marrow Transplantation --;7.9 Summary and Conclusions --;Acknowledgement --;References --;8. The Role of Marrow Transplantation in the Treatment of Leukemia --;8.1 Introduction --;8.2 Donor Selection --;8.3 Preparative Regimens --;8.4 Techniques of Marrow Transplantation --;8.5 Clinical Results in Acute Nonlymphoblastic Leukemia (ANL) --;8.6 Clinical Results in Acute Lymphoblastic Leukemia (ALL) --;8.7 Clinical Results in Chronic Granulocytic Leukemia (CGL) --;8.8 Leukemic Recurrence After Transplantation --;8.9 Graft-Versus-Host Disease (GVHD) --;8.10 Infectious Complications, Including Interstitial Pneumonia --;8.11 Other Organ Toxicities --;8.12 Summary --;Acknowledgements --;References --;9 Hyperleukemias in Adult Leukemia --;9.1 Introduction --;9.2 Acute Myelocytic Leukemia --;9.3 Chronic Myelocytic Leukemia --;9.4 Acute Lymphocytic Leukemia --;10 New Developments in the Etiology, Diagnosis, Treatment and Prevention of Infectious Complications in Patients with Leukemia --;10.1 Introduction --;10.2 Changing Patterns of Infections --;10.3 New Developments in Evaluation and Diagnosis --;10.4 Developments in Antimicrobial Therapy --;10.5 New or Evolving Syndromes in Management of Infections in the Adult Leukemic --;10.6 Recent Developments in Adjuvant Therapy --;10.7 Current Concepts in Infection Prevention in Acute Leukemia.
It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription.